ABT (Abbott Laboratories) Payments of Debt: $-2,006 Mil (TTM As of Mar. 2026)


ABT Abbott Laboratories ABT
80 GF Score
Price $95.40
GF Value $129.98
Valuation Modestly Undervalued
View Full Analysis

What is Abbott Laboratories Payments of Debt?

Abbott Laboratories ABT +3.49% 80 Payments of Debt is $-2,006 Mil as of Mar. 2026. GuruFocus rates ABT with a GF Score™ of 80/100 and a GF Value™ of $129.98 (Modestly Undervalued).

Abbott Laboratories's Payments of Debt for the three months ended in Mar. 2026 was $-1,416 Mil.

Abbott Laboratories's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was $-2,006 Mil.

Abbott Laboratories Payments of Debt Related Terms

Abbott Laboratories Payments of Debt Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Payments of Debt Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -252.00 -753.00 -2,498.00 -760.00 -1,619.00

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,037.00 -17.00 -501.00 -72.00 -1,416.00
ABT
80GF Score
Abbott Laboratories ABT
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2,006 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-2,006 Mil mean?
Abbott Laboratories (ABT) has a Payments of Debt of $-2,006 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Payments of Debt too high?
Abbott Laboratories' current Payments of Debt is $-2,006 Mil. Overall, Abbott Laboratories has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Payments of Debt compare to SYK and MDT?
Abbott Laboratories' Payments of Debt of $-2,006 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Medical Devices & Instruments company?
A good Payments of Debt depends on the Medical Devices & Instruments industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Payments of Debt is $-2,006 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Modestly Undervalued. The stock's GF Value™ is $129.98, compared to a current price of $95.40 — trading 26.6% below its estimated fair value. The current Payments of Debt is $-2,006 Mil. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current Payments of Debt is $-2,006 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of $95.40 is trading 26.6% below its estimated GF Value™ of $129.98. GuruFocus considers Abbott Laboratories to be Modestly Undervalued.

Key valuation signals for ABT:

  • Payments of Debt: $-2,006 Mil
  • GF Value™: $129.98 vs. price of $95.40 (26.6% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for ABT

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$95.40
Price
$129.98
GF Value